Amphastar Pharmaceuticals Inc

AMPHNASDAQ · USD
29.37USD0.00 (+1.74%)
10910

Amphastar Pharmaceuticals Inc (AMPH) Covered Calls

Amphastar Pharmaceuticals Inc trades in the Drug Manufacturers - Specialty & Generic industry with an IV Rank of 45.63%, average versus the past year. AMPH's highest covered call setup is the $35.00 strike expiring Jun 17, 2027, sorted by theoretical annualized return. It's 21.23% out of the money with 217 days to expiration, a 21.93% return until expiration, and a 36.88% theoretical annualized return. Across the setups shown, annualized returns run from 24.06% to 36.88% at strikes between $30.00 and $35.00, with 127 to 217 days to expiration, as of Nov 12, 2026.

Read more

Running AMPH covered calls helps you generate income from Amphastar Pharmaceuticals Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best AMPH covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If AMPH stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling AMPH covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given AMPH covered call is worth writing.

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency.

2027-06-1721735.0021.230.203.00633.0021.9336.88-0.69+0.3392.80
2027-03-1912730.003.911.305.00243.008.4224.19-4.50+0.53153.70
2027-06-1721730.003.913.006.00413.0014.3124.06-10.39+0.5743.00

As of Nov 12, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

  • IndustryDrug Manufacturers - Specialty & Generic
  • SectorHealthcare
  • IV Rank45.63% Moderate
  • Market cap (M$)1,253
  • 52 weeks high-5.26%
  • 52 weeks low76.50%
  • Analyst recommendationHold
    3.14
  • Target price$24.50
    -16.58% below the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2026-11-05
  • P/E13.27
  • Future P/E8.76
  • EPS (ttm)2.21
  • EPS growth next 5 years3.20%

As of Nov 13, 2026